Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area

PURPOSE: Lactate dehydrogenase (LDH), which was an indirect marker of hypoxia, was a potentially prognostic factor in several malignancies. There is a lack of evidence about the prognostic value of serum LDH level in patients with hepatocellular carcinoma (HCC) receiving sorafenib treatment from hep...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mu-xing, Zhao, Hong, Bi, Xin-yu, Li, Zhi-yu, Yao, Xue-song, Li, Huai, Huang, Zhen, Han, Yue, Zhou, Jian-guo, Zhao, Jian-jun, Zhang, Ye-fan, Zhao, Dong-bin, Cai, Jian-qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349941/
https://www.ncbi.nlm.nih.gov/pubmed/27880930
http://dx.doi.org/10.18632/oncotarget.13428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349941/
https://www.ncbi.nlm.nih.gov/pubmed/27880930
http://dx.doi.org/10.18632/oncotarget.13428

Ejemplares similares